The following is an excerpt.
In the majority of patients with papillary thyroid cancer, the most common form of thyroid cancer, there is no need for genetic testing. However, there might be a role for such testing in the 7% of patients who present with an aggressive form of the disease.
This finding comes from a study published in the April 10 issue of JAMA that explores the association between the BRAFV600E mutation and mortality in patients with papillary thyroid cancer.
Read the full article here: No Need for Genetic Testing for Most Thyroid Cancers
